In an in vitro study evaluating the effects of Hesperidin on the immunoreactivity of tau, β-amyloid, and α-synuclein, it demonstrated neuroprotective effect by significantly lowering α-synuclein values in an in vitro AD model produced by Aβ25–35 [27]. The gene discussed is MAPT; the disease is Alzheimer disease.